COMMUNIQUÉS West-GlobeNewswire

Vaccinex, Inc. Presented Previously Disclosed Data from Ongoing Phase 1/2 Trial of VX15/2503 (Pepinemab) in Huntington’s Disease (the “SIGNAL Trial”) at Cambridge Healthtech Institute’s 18th Annual PepTalk
17/01/2019
ROCHESTER, N.Y., Jan. 17, 2019 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and [...]
FSD Pharma & Canntab Rank Among the Top 2018 Cannabis Stocks -- CFN Media
17/01/2019
SEATTLE, Jan. 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Hemostemix Provides Highlights of 2018 Accomplishments
17/01/2019
CALGARY, Alberta, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to provide the following corporate update on accomplishments and [...]
Agritek Holdings, Inc. Announces December Sales of Approximately 2,000 MD Vapes Units to Florida Market With New White Label Deals for Customized CBD and THC Formulas to Top Colorado and Puerto Rico Retail Dispensaries
17/01/2019
LOS ANGELES, CA, Jan. 17, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Agritek Holdings, Inc. (OTC PINK: AGTK) www.AgritekHoldings.com , a fully integrated, active cannabis real estate investor and brand licensor for the [...]
Abattis Removed From BCSC Temporary Order
17/01/2019
VANCOUVER, British Columbia, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “ Company ” or “ Abattis ”) (CSE:ATT) (OTC:ATTBF) is pleased to announce that the temporary order from the British Columbia [...]
Organovo Announces Release Date for Fiscal Third-Quarter 2019 Financial Results
17/01/2019
SAN DIEGO, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, February 7, 2019 at 5:00 p.m. Eastern Time (ET) to discuss the Company's fiscal [...]
Healthwise and Docola Partner to Deliver Health Education
17/01/2019
BOISE, Idaho, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Healthwise, a leader in evidence-based health education, technology, and services, and Docola, an organization that provides an integrated patient education marketplace, [...]
Gala Pharmaceutical to Present at World Cbd Expo
17/01/2019
IRVINE, Calif., Jan. 17, 2019 (GLOBE NEWSWIRE) -- Gala Pharmaceutical, Inc. (OTC: GLPH), a provider of cannabis testing in Southern California, today announced that Gala Pharmaceutical Inc. will be presenting at the [...]
AMAG Pharmaceuticals Completes Acquisition of Perosphere Pharmaceuticals
17/01/2019
Adds Next Generation Small Molecule Anticoagulant Reversal Agent to Development Pipeline to Leverage AMAG’s Expertise in Hematology WALTHAM, Mass., Jan. 17, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: [...]
RedHill Biopharma Announces Fifth U.S. Patent Covering TALICIA® for H. pylori Infection
17/01/2019
Notice of Allowance received and, once granted, the new U.S. patent is expected to be valid until 2034 NDA submission is expected in H1/2019, with eligibility for 6-month priority review; Subject to FDA approval, U.S. [...]
Geron Appoints Vice President, Pharmacovigilance and Drug Safety
17/01/2019
MENLO PARK, Calif., Jan. 17, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced the hiring of the first of several key leadership positions as it rebuilds the in-house development team to support [...]
Rafael Pharmaceuticals to Present Plan for Phase 3 Trial (AVENGER 500) of devimistat (CPI-613®) in Combination with Modified FOLFIRINOX as a First Line Treatment for Metastatic Pancreatic Cancer at 2019 Gastrointestinal Cancers Symposium
17/01/2019
Newark, NJ, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, today announced that the study plan for a Phase 3 Trial (AVENGER 500) of [...]
Wellness Matrix Group To Initiate State-of-the-Art Wellness Model Program
17/01/2019
LOS ANGELES, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Wellness Matrix Group, Inc. (OTC:WMGR) announces today that it will shortly introduce what it considers the world's most technologically advanced health care models in [...]
Progressive Care Releases Open Letter to Shareholders
17/01/2019
Open Letter to Shareholders Summarizes Recent Milestones MIAMI, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), through its PharmCo subsidiaries, is a South Florida health services organization and [...]
Quotient Limited to Report Fiscal Third Quarter 2019 Financial Results and Host Conference Call
17/01/2019
JERSEY, Channel Islands, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal third quarter ended December 31, [...]
Canopy Rivers Appoints Former OMERS Venture Capital Specialist as President
17/01/2019
TORONTO, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Canopy Rivers Inc. (the “ Company ” or “ Canopy Rivers ”) (TSXV: RIV) today announced that Narbe Alexandrian has been appointed as President of the Company, effective [...]
American Postal Workers Union Health Plan Selects Inovalon ONE® Platform
17/01/2019
Partnership Focuses on Leveraging Advanced Analytics and Technologies to Improve Quality and Financial Performance BOWIE, Md. , Jan. 17, 2019 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading technology company [...]
Ossur Hf : Q4&FY 2018 Results - Conference call Tuesday 5 February at 9:00 CET
17/01/2019
Announcement no. 03/2018 17 January 2019 Conference call on Tuesday 5 February at 9:00 CET / 8:00 GMT / 3:00 EDT Össur will publish its financial results for Q4&FY 2018 prior to market opening on Tuesday 5 February [...]
ProMIS Neurosciences to Participate in NobleCon15 and CanTech Investment Conferences
17/01/2019
Company to showcase its innovative Alzheimer’s, Parkinson’s and ALS programs TORONTO and CAMBRIDGE, Mass., Jan. 17, 2019 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company [...]

Pages